Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (135) Arrow Down
Filter Results: (135) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (135)
    • News  (17)
    • Research  (104)
    • Events  (1)
  • Faculty Publications  (32)

Show Results For

  • All HBS Web  (135)
    • News  (17)
    • Research  (104)
    • Events  (1)
  • Faculty Publications  (32)
← Page 5 of 135 Results →
  • 07 Aug 2006
  • Research & Ideas

Whatever Happened to Caveat Emptor?

basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
Keywords: by Sean Silverthorne; Retail
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 16 Oct 2013
  • Op-Ed

Response to Readers: Combating Climate Change with Nuclear Power and Fracking

With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
Keywords: by Joe Lassiter; Energy; Utilities
  • 22 May 2020
  • In Practice

Post-COVID Health Care: More Screens, Less Red Tape?

Fetter, a senior lecturer, is former CEO of Tenet Healthcare. Regulations that limit care might be loosened Richard Hamermesh: Cutting the red tape in diagnostic testing The crisis has revealed the weakest part of our medical system—the... View Details
Keywords: by Danielle Kost
  • 13 Jul 2009
  • Research & Ideas

Diagnosing the Public Health Care Alternative

onto patients. To work, a public plan must be regulated and have independent governance, and, if it is well-designed, it might inspire competition from private insurers—leading to better value for patients. Regina E. Herzlinger, The Nancy... View Details
Keywords: by Staff; Health
  • 12 May 2008
  • Research & Ideas

Accounting Information as Political Currency

developed and fast-developing nations. Data on legislative-election vote shares are also likely available for many jurisdictions. The data on cash contributions from companies to politicians will be tricky—the United States has relatively better disclosure View Details
Keywords: by Martha Lagace
  • 19 Oct 2015
  • Research & Ideas

Business Research that Makes for Smarter Public Policy

originated. “We are using data from regulators, writing studies, but seldom going back to the regulators to say, ‘This is what we learned,’” says Harvard Business School Professor Michael W. Toffel, whose research examines companies’... View Details
Keywords: by Michael Blanding
  • 12 Feb 2019
  • First Look

New Research and Ideas, February 12, 2019

Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like... View Details
Keywords: Dina Gerdeman
  • 11 May 2010
  • First Look

First Look: May 11

United States, expanding coverage and regulating insurers. However, it was not clear that expanding coverage would resolve a longstanding dilemma of rising costs for insurance and care. As the Department of Health and Human Services... View Details
Keywords: Martha Lagace
  • 26 Feb 2019
  • First Look

New Research and Ideas, February 26, 2019

Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and... View Details
Keywords: Dina Gerdeman
  • 01 Sep 2010
  • News

Letters to the Editor

Wells states, “I would hesitate to have those kinds of financial dealings thought of as equivalent to the problems of drug money, or terrorist financing, or secreted money from blatant bribes.” Maybe so. But the ethics of tax cheats are... View Details
Keywords: Securities, Commodities, and Other Financial Investments; Finance
  • 14 Apr 2021
  • Research & Ideas

The High Cost of the Slow COVID Vaccine Rollout

the United States, the Federal Drug Administration this week advised states to pause the use of the Johnson & Johnson vaccine after six women developed a rare blood-clotting disorder, raising new concerns about total vaccine supply.... View Details
Keywords: by Michael Blanding; Health
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven... View Details
Keywords: Martha Lagace
  • 01 Jun 2020
  • News

Prognosis

of telemedicine. At MGH these virtual visits skyrocketed, allowing patients and doctors to reduce the risk of spreading the virus. How did that change come about so suddenly, after years of existing on the fringes? Robert Huckman: What we’ve seen is at least a... View Details
Keywords: Jen McFarland Flint; COVID-19; Hospitals; Health, Social Assistance
  • 30 Oct 2007
  • First Look

First Look: October 30, 2007

Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
  • 25 Aug 2015
  • First Look

First Look Tuesday

may be less effective in protecting financial stability. Our analysis sheds light on the fundamental tensions inherent in regulating the shadow banking system. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=49510 2015... View Details
  • 25 Oct 2016
  • First Look

October 25, 2016

insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and... View Details
Keywords: Sean Silverthorne
  • 01 Mar 2019
  • News

The Blue-Green Revolution

algae Nannochloropsis gaditana and uncovered a group of genes responsible for regulating oil production. By tweaking one of those genes with the powerful editing tool known as CRISPR, the team ultimately doubled the amount of oil produced... View Details
Keywords: Alexander Gelfand; illustration by Eric Nyquist
  • 27 Mar 2012
  • First Look

First Look: March 27

Emissions Regulation Authors:David Drake, Paul R. Kleindorfer, and Luk N. Van Wassenhove Abstract We study the impact of emissions tax and emissions cap-and-trade regulation on a firm's long-run technology... View Details
Keywords: Carmen Nobel
  • 25 Feb 2014
  • First Look

First Look: February 25

in the country's economy during the past two decades, have brought together a group of economists and political scientists to systematically examine the impact of a wide range of factors affecting the economy's collapse, from the cost of labor View Details
Keywords: Sean Silverthorne
  • ←
  • 5
  • 6
  • 7
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.